1. Home
  2. AURA vs SRTA Comparison

AURA vs SRTA Comparison

Compare AURA & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • SRTA
  • Stock Information
  • Founded
  • AURA 2007
  • SRTA 2014
  • Country
  • AURA United States
  • SRTA United States
  • Employees
  • AURA N/A
  • SRTA N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • SRTA
  • Sector
  • AURA Health Care
  • SRTA
  • Exchange
  • AURA Nasdaq
  • SRTA Nasdaq
  • Market Cap
  • AURA 396.8M
  • SRTA 438.4M
  • IPO Year
  • AURA 2021
  • SRTA N/A
  • Fundamental
  • Price
  • AURA $5.49
  • SRTA $4.45
  • Analyst Decision
  • AURA Strong Buy
  • SRTA Strong Buy
  • Analyst Count
  • AURA 5
  • SRTA 1
  • Target Price
  • AURA $21.80
  • SRTA $7.25
  • AVG Volume (30 Days)
  • AURA 232.9K
  • SRTA 818.7K
  • Earning Date
  • AURA 11-13-2025
  • SRTA 11-10-2025
  • Dividend Yield
  • AURA N/A
  • SRTA N/A
  • EPS Growth
  • AURA N/A
  • SRTA N/A
  • EPS
  • AURA N/A
  • SRTA 0.50
  • Revenue
  • AURA N/A
  • SRTA $268,618,000.00
  • Revenue This Year
  • AURA N/A
  • SRTA N/A
  • Revenue Next Year
  • AURA N/A
  • SRTA $28.16
  • P/E Ratio
  • AURA N/A
  • SRTA $9.55
  • Revenue Growth
  • AURA N/A
  • SRTA 70.11
  • 52 Week Low
  • AURA $4.35
  • SRTA $2.35
  • 52 Week High
  • AURA $9.79
  • SRTA $6.02
  • Technical
  • Relative Strength Index (RSI)
  • AURA 41.61
  • SRTA N/A
  • Support Level
  • AURA $5.18
  • SRTA N/A
  • Resistance Level
  • AURA $5.87
  • SRTA N/A
  • Average True Range (ATR)
  • AURA 0.27
  • SRTA 0.00
  • MACD
  • AURA -0.02
  • SRTA 0.00
  • Stochastic Oscillator
  • AURA 25.48
  • SRTA 0.00

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About SRTA Strata Critical Medical Inc. Class A Common Stock

Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.

Share on Social Networks: